Advertisement
05/23/2023

Alembic intros Docetaxel injection

Docetaxel injection is a microtubule inhibitor indicated for treating patients with several types of cancer after failure of prior chemotherapy.
Sandra Levy
Senior Editor
Sandra Levy profile picture

Alembic is introducing Docetaxel injection, 20 mg/2 ml (10 mg/ml), 80 mg/8 ml (10 mg/ml) and 160 mg/16 ml (10 mg/ml), which is the generic of Hospira’s Docetaxel injection.

Docetaxel injection is a microtubule inhibitor. It is indicated for treating patients with locally advanced or metastatic breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma and squamous cell carcinoma of the head and neck after the failure of prior chemotherapy.

[Read more: Alembic rolls out generic Hygroton]

Alembic will offer Docetaxel injection in 20 mg/2 ml single-dose vials, and 80 mg/8 ml and 160 mg/16 ml multiple-dose vials.

    Advertisement
    Advertisement